<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate the molecular events in the genome that are associated with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and the development of <z:hpo ids='HP_0001909'>leukemia</z:hpo>, we investigated the expression of the deleted in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:chebi fb="8" ids="53090">DCC</z:chebi>) gene by the reverse transcriptase-polymerase chain reaction (RTPCR) method in 24 MDS cases and in 7 overt <z:hpo ids='HP_0001909'>leukemia</z:hpo> cases that progressed from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of the <z:chebi fb="8" ids="53090">DCC</z:chebi> gene was absent or extremely reduced in 2 of the 24 MDS cases, and those 2 cases developed overt <z:hpo ids='HP_0001909'>leukemia</z:hpo> within 6 months </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, in 5 of the 7 cases of overt <z:hpo ids='HP_0001909'>leukemia</z:hpo> that developed from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, expression of the <z:chebi fb="8" ids="53090">DCC</z:chebi> gene was absent or extremely reduced </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggest that inactivation of the <z:chebi fb="8" ids="53090">DCC</z:chebi> gene may be the late event that triggers the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>